Letter: Cycloserine and tuberulous meningitis

Effects of cefotaxime on the serum protein binding of sulfisoxazole.

Biopharmaceutics & drug disposition·1990

Decrease in penbutolol central response as a cause of changes in its serum protein binding.

The Journal of pharmacy and pharmacology·1990

Serum protein binding of sulfisoxazole and diazepam in patients with chronic obstructive pulmonary disease.

International journal of clinical pharmacology, therapy, and toxicology·1987

Relationship between changes in seromucoid concentrations and the rate of oxidation or acetylation of several substrates.

Drug metabolism and disposition: the biological fate of chemicals·1986

Differential effects of valproic acid on the serum protein binding of lorazepam and diazepam.

International journal of clinical pharmacology research·1986

Serum protein binding of model acidic drugs in smokers and non-smokers.

International journal of clinical pharmacology research·1986

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Tetracyclic triterpenes from Chios Mastic Gum act as TGR5 and RORγ modulators.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

Pursuing the Red-Shift in GlycoporphyrinsA New Synthetic Approach toward Glycoconjugates from the meso-Tetraethynylporphyrin Scaffold.

ACS organic & inorganic Au·2026

A water-soluble pyrene-based diimidazolium molecular probe enabling chirality and fluorescence dual-response toward G-quadruplexes.

Chemical science·2026

Acute glucagon infusion induces natriuresis and diuresis through a direct tubular mechanism involving overlapping receptor pathways.

American journal of physiology. Renal physiology·2026

Structural and Functional Insights Into (S)-5'-C-Guanidinopropyl Uridine-Modified Oligonucleotides With 2'-O-Methyl and 2'-Fluoro Substitutions for RNAi Therapeutics.

ChemMedChem·2026

Effect of semaglutide on kidney outcomes in the SELECT, FLOW, and SOUL trials: a prespecified pooled analysis.

The lancet. Diabetes & endocrinology·2026

Related Experiment Videos

Letter: Cycloserine and tuberulous meningitis

Related Concept Videos

Effects of cefotaxime on the serum protein binding of sulfisoxazole.

Decrease in penbutolol central response as a cause of changes in its serum protein binding.

Serum protein binding of sulfisoxazole and diazepam in patients with chronic obstructive pulmonary disease.

Relationship between changes in seromucoid concentrations and the rate of oxidation or acetylation of several substrates.

Differential effects of valproic acid on the serum protein binding of lorazepam and diazepam.

Serum protein binding of model acidic drugs in smokers and non-smokers.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Tetracyclic triterpenes from Chios Mastic Gum act as TGR5 and RORγ modulators.

Pursuing the Red-Shift in GlycoporphyrinsA New Synthetic Approach toward Glycoconjugates from the meso-Tetraethynylporphyrin Scaffold.

A water-soluble pyrene-based diimidazolium molecular probe enabling chirality and fluorescence dual-response toward G-quadruplexes.

Acute glucagon infusion induces natriuresis and diuresis through a direct tubular mechanism involving overlapping receptor pathways.

Structural and Functional Insights Into (S)-5'-C-Guanidinopropyl Uridine-Modified Oligonucleotides With 2'-O-Methyl and 2'-Fluoro Substitutions for RNAi Therapeutics.

Effect of semaglutide on kidney outcomes in the SELECT, FLOW, and SOUL trials: a prespecified pooled analysis.

Related Experiment Videos

Letter: Cycloserine and tuberulous meningitis

Related Concept Videos

Related Articles